Lin Qin

机构：Yangtze University, Zunyi Medical University, First Affiliated Hospital of Xiamen University, Hangzhou DAC Biotech (China)

发表论文 48 篇 · 总被引 432 次 · h-index 12

代表论文

• Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism (2023 · PeerJ · 被引 46)
• Jiangu granules ameliorate postmenopausal osteoporosis via rectifying bone homeostasis imbalance: A network pharmacology analysis based on multi-omics validation (2023 · Phytomedicine · 被引 43)
• Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome (2023 · Molecules · 被引 33)
• Single-Cell RNA Transcriptome Profiling of Liver Cells of Short-Term Alcoholic Liver Injury in Mice (2023 · International Journal of Molecular Sciences · 被引 21)
• The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice (2023 · Drug Metabolism Reviews · 被引 19)
• A machine learning-based PET/CT model for automatic diagnosis of early-stage lung cancer (2023 · Frontiers in Oncology · 被引 16)